SCHEMBL24079191

SCHEMBL24079191

CCCCc1cc2nn[nH]c2c(O)c1C(C)=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 3/20 0.37
HCAR3 P49019 2/20 0.37
PRKCI P41743 1/20 0.35
NR1H4 Q96RI1 2/20 0.35
PDE2A O00408 1/20 0.33
PDE1A P54750 1/20 0.33
PDE1B Q01064 1/20 0.33
PDE1C Q14123 1/20 0.33
GPR35 Q9HC97 1/20 0.33
PPARG P37231 1/20 0.33
PPARD Q03181 1/20 0.33
PPARA Q07869 1/20 0.33
CYSLTR2 Q9NS75 2/20 0.32
CYSLTR1 Q9Y271 2/20 0.32
GABRP O00591 1/20 0.32
GABRD O14764 1/20 0.32
GABRA1 P14867 1/20 0.32
GABRB1 P18505 1/20 0.32
GABRG2 P18507 1/20 0.32
GABRB3 P28472 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15782865 0.88 PRKCI (0.33) HCAR2PRKCI
SCHEMBL19841043 0.79 PRKCI (0.35) HCAR2HCAR3PRKCINR1H4PPARG
SCHEMBL19841048 0.73 PRKCI (0.37) HCAR2HCAR3PRKCIPPARGPPARD
SCHEMBL19841055 0.73 PRKCI (0.35) HCAR2HCAR3PRKCINR1H4PPARG
SCHEMBL21569598 0.72 PRKCI (0.39) PRKCIPPARGPPARDPPARATYR
SCHEMBL21569592 0.71 PRKCI (0.35) HCAR2HCAR3PRKCIGPR35PPARG
SCHEMBL19841041 0.70 GABRP (0.36) HCAR2HCAR3PRKCINR1H4PPARG
SCHEMBL9228593 0.70 TLR8 (0.38) HCAR2HCAR3PDE2APDE1APDE1B
SCHEMBL9227489 0.70 TLR8 (0.39) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL19841057 0.69 PRKCI (0.38) HCAR2HCAR3PRKCIPPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11192866-B2 Synthesis of tetracyclines and analogues thereof PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2021-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11192866-B2 Synthesis of tetracyclines and analogues thereof TET1, TET3, MYC HCAR2 3521/4885HCAR3 3717/4885PRKCI 2091/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.